ClinicalTrials.Veeva

Menu

Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients (SurviTreat)

V

Vastra Gotaland Region

Status

Enrolling

Conditions

Rheumatoid Arthritis

Treatments

Drug: methotrexate
Drug: abatacept
Drug: tofacitinib/baricitinib
Drug: tocilizumab
Drug: sulfasalazine

Study type

Observational

Funder types

Other

Identifiers

NCT03440892
Survivin in Treatment

Details and patient eligibility

About

To validate the utility of survivin as a biomarker of pharmacological response to therapeutic intervention in rheumatoid arthritis patients.

Full description

In a prospective observational study the investigators aim to study the ability of modern antirheumatic treatments to suppress levels of survivin in sera. Rheumatoid arthritis patients scheduled to start new pharmacological treatment will be followed for a period of 6 months. No intervention or influence on choice of treatment will be performed, the decision of new/other medication is entirely made by the patient and their rheumatologist. The study entails addition of survivin analyse (1 vial of sera) before and after start of new treatment. Data concerning survivin levels, disease activity and other clinical parameters before and after start of new treatment will also be analysed. The patients will leave sera for survivin analyse at baseline and 3 and 6 months after start of new treatment.

Enrollment

2,500 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients fulfilling the RA classification criteria according to the ACR/EULAR

Exclusion criteria

  • Patients at stable/unchanged anti-rheumatic treatment
  • Other serious physical or mental illness
  • Lack of knowledge in Swedish making answering the questionnaires impossible

Trial design

2,500 participants in 1 patient group

1
Treatment:
Drug: sulfasalazine
Drug: methotrexate
Drug: tocilizumab
Drug: tofacitinib/baricitinib
Drug: abatacept

Trial contacts and locations

1

Loading...

Central trial contact

Maria Bokarewa, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems